CENTRAL TRUST Co increased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 10.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,193 shares of the semiconductor company’s stock after buying an additional 315 shares during the quarter. CENTRAL TRUST Co’s holdings in Synopsys were worth $269,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of SNPS. Deutsche Bank AG lifted its position in shares of Synopsys by 50.3% during the 3rd quarter. Deutsche Bank AG now owns 1,925,800 shares of the semiconductor company’s stock worth $189,896,000 after buying an additional 644,307 shares during the period. Wells Fargo & Company MN increased its holdings in Synopsys by 32.1% during the 3rd quarter. Wells Fargo & Company MN now owns 1,340,021 shares of the semiconductor company’s stock valued at $132,140,000 after purchasing an additional 325,570 shares in the last quarter. Renaissance Technologies LLC increased its holdings in Synopsys by 44.7% during the 3rd quarter. Renaissance Technologies LLC now owns 1,045,834 shares of the semiconductor company’s stock valued at $103,130,000 after purchasing an additional 322,900 shares in the last quarter. Franklin Resources Inc. increased its holdings in Synopsys by 71.3% during the 3rd quarter. Franklin Resources Inc. now owns 737,863 shares of the semiconductor company’s stock valued at $72,761,000 after purchasing an additional 307,144 shares in the last quarter. Finally, Vanguard Group Inc increased its holdings in Synopsys by 1.3% during the 3rd quarter. Vanguard Group Inc now owns 15,851,502 shares of the semiconductor company’s stock valued at $1,563,115,000 after purchasing an additional 204,619 shares in the last quarter. Institutional investors and hedge funds own 88.55% of the company’s stock.

NASDAQ SNPS opened at $87.71 on Friday. The firm has a market capitalization of $13.00 billion, a PE ratio of 31.11, a PEG ratio of 3.26 and a beta of 1.22. Synopsys, Inc. has a 52 week low of $79.14 and a 52 week high of $103.40. The company has a quick ratio of 0.68, a current ratio of 0.73 and a debt-to-equity ratio of 0.04.

Synopsys (NASDAQ:SNPS) last released its earnings results on Wednesday, December 5th. The semiconductor company reported $0.78 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.41 by $0.37. The company had revenue of $795.08 million during the quarter, compared to analysts’ expectations of $794.55 million. Synopsys had a return on equity of 16.91% and a net margin of 13.86%. As a group, equities research analysts expect that Synopsys, Inc. will post 2.67 EPS for the current year.

In related news, CEO Chi-Foon Chan sold 3,611 shares of Synopsys stock in a transaction on Friday, December 7th. The stock was sold at an average price of $88.28, for a total transaction of $318,779.08. Following the completion of the sale, the chief executive officer now directly owns 198,633 shares of the company’s stock, valued at $17,535,321.24. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Joseph W. Logan sold 20,000 shares of Synopsys stock in a transaction on Friday, December 7th. The stock was sold at an average price of $89.18, for a total value of $1,783,600.00. Following the sale, the executive vice president now directly owns 88,271 shares of the company’s stock, valued at $7,872,007.78. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 73,611 shares of company stock valued at $6,569,379. 1.84% of the stock is owned by insiders.

SNPS has been the subject of a number of recent analyst reports. Berenberg Bank initiated coverage on Synopsys in a report on Tuesday, November 20th. They set a “buy” rating and a $119.00 price target for the company. Zacks Investment Research raised Synopsys from a “hold” rating to a “buy” rating and set a $99.00 price target for the company in a report on Tuesday, October 23rd. JPMorgan Chase & Co. raised Synopsys from an “underweight” rating to a “neutral” rating and set a $98.00 price target for the company in a report on Tuesday, October 23rd. Benchmark raised Synopsys from a “hold” rating to a “buy” rating and set a $110.00 price target for the company in a report on Thursday, December 6th. Finally, BidaskClub cut Synopsys from a “strong-buy” rating to a “buy” rating in a report on Wednesday, September 19th. One research analyst has rated the stock with a sell rating, one has given a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Synopsys has a consensus rating of “Buy” and an average target price of $109.25.

TRADEMARK VIOLATION WARNING: “CENTRAL TRUST Co Has $269,000 Position in Synopsys, Inc. (SNPS)” was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at https://theolympiareport.com/2019/01/12/central-trust-co-has-269000-position-in-synopsys-inc-snps.html.

Synopsys Profile

Synopsys, Inc provides electronic design automation (EDA) software products used to design and test integrated circuits (ICs). It offers Galaxy Design platform that offers IC design solutions; Verification Continuum Platform, which provides virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Article: What is the float in trading stocks?

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.